Product Information
INVEGA TRINZA 819 MG/2.63 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $3995.1063 per ML under NDC 50458060901. Its NADAC has been published 553 times since Jan 20, 2016.
FDA first approved this application on May 18, 2015.
Strength
819 mg/2.63mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458060901
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
PALIPERIDONE PALMITATEApproval Type
New Drug (NDA)
FDA Application
NDA207946FDA Approved
5/18/2015
On Market Since
5/19/2015
Pharmacological Classes
Price Statistics
The NADAC for INVEGA TRINZA 819 MG/2.63 ML has been published 553 times since Jan 20, 2016, and over the history we have for it it has risen 71.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3995.1063 per ML |
|---|---|
| All-time high | $4007.7811 (Jun 10, 2026) |
| All-time low | $2336.6117 (Jan 20, 2016) |
| 52-week high | $4007.7811 |
| 52-week low | $3880.4162 |
| Median price | $3235.2424 |
| Average price | $3219.2485 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 553 |
| Tracking since | Jan 20, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVEGA TRINZA 819 MG/2.63 ML?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA TRINZA 819 MG/2.63 ML, manufactured by Janssen Pharmaceuticals Inc., is $3995.1063 per ML (NDC 50458060901), effective Aug 19, 2026.
How has the price of INVEGA TRINZA 819 MG/2.63 ML changed over time?
Over the history we have for it, the NADAC for INVEGA TRINZA 819 MG/2.63 ML has risen 71.0%. It has been tracked across 553 weekly CMS publications since Jan 20, 2016.
What are the highest and lowest recorded NADAC prices for INVEGA TRINZA 819 MG/2.63 ML?
Since Jan 20, 2016, the NADAC for INVEGA TRINZA 819 MG/2.63 ML has ranged from a low of $2336.6117 (Jan 20, 2016) to a high of $4007.7811 (Jun 10, 2026), with a median of $3235.2424 per ML.
Are there cheaper alternatives to INVEGA TRINZA 819 MG/2.63 ML?
No other NADAC-published product currently shares the active ingredient and strength of INVEGA TRINZA 819 MG/2.63 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INVEGA TRINZA 819 MG/2.63 ML?
INVEGA TRINZA 819 MG/2.63 ML (NDC 50458060901) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.